- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07332286
FANS-Assisted Mini-PCNL for Complex Renal Stones (FANS-MiniPerc)
Mini-percutaneous Nephrolithotomy With a Flexible Mini-nephroscope and a Flexible and Navigable Suction Access Sheath for Complex Renal Stones: A Prospective Pilot Study
This prospective pilot study aims to evaluate the feasibility, safety, and preliminary clinical outcomes of a novel mini-percutaneous nephrolithotomy (mini-PCNL) technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) for the treatment of complex renal stones.
Thirty consecutive patients with renal stones ≥2 cm will be prospectively enrolled. All patients will undergo FANS-assisted mini-PCNL. The primary outcome is the immediate stone-free rate assessed by non-contrast CT within 72 hours after surgery. Secondary outcomes include operative parameters, postoperative pain, complications, length of hospital stay, and quality of life.
This pilot study is designed to provide preliminary evidence supporting the feasibility and safety of FANS-assisted mini-PCNL and to inform the design of future larger-scale studies.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Conventional mini-PCNL may be limited by restricted access to anatomically challenging calyces and inefficient evacuation of stone fragments when flexible nephroscopy is required.
A novel technique integrating a flexible mini-nephroscope with a flexible and navigable suction access sheath (FANS) has been developed to enable flexible intrarenal navigation combined with active suction during antegrade lithotripsy.
This prospective pilot study will enroll 30 consecutive patients undergoing FANS-assisted mini-PCNL for complex renal stones. The study focuses on feasibility, safety, and preliminary clinical outcomes, including stone clearance and perioperative morbidity. The results will serve as preliminary data for future confirmatory or comparative clinical trials.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510230
- The First Affiliated Hospital of Guangzhou Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 to 75 years
- Patients with renal stones measuring 2 cm or larger in maximum diameter
- American Society of Anesthesiologists (ASA) physical status classification I-III
- Planned to undergo mini-percutaneous nephrolithotomy
- Able and willing to provide written informed consent
Exclusion Criteria:
- Uncontrolled urinary tract infection at the time of surgery
- Known bleeding tendency or coagulation disorders
- Contraindication to general anesthesia
- Pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FANS-assisted mini-PCNL
Mini-percutaneous nephrolithotomy performed using a flexible mini-nephroscope combined with a flexible and navigable suction access sheath to facilitate flexible access and active stone fragment evacuation.
|
The procedure consists of mini-percutaneous nephrolithotomy (mini-PCNL) performed with the assistance of a flexible mini-nephroscope and a flexible and navigable suction access sheath (FANS). Following standard percutaneous renal access and initial stone fragmentation using a rigid nephroscope, a flexible mini-nephroscope is introduced through the percutaneous tract to access calyces that are difficult to reach with rigid instruments. Holmium:YAG laser lithotripsy is then performed under flexible endoscopic visualization. The flexible and navigable suction access sheath allows simultaneous irrigation and adjustable negative-pressure suction, enabling continuous evacuation of stone fragments during lithotripsy. Suction strength can be regulated intraoperatively to maintain a clear endoscopic field and facilitate controlled fragment removal. This procedure is applied to all participants in this prospective pilot study and aims to evaluate the feasibility and safety of flexible suction
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Immediate stone-free rate
Time Frame: Postoperative day 0 to 3
|
Absence of residual stones or fragments >2 mm detected by non-contrast CT
|
Postoperative day 0 to 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stone-free rate at 1 month
Time Frame: Postoperative day 30 (±7 days)
|
Absence of residual stones or fragments >2 mm detected by non-contrast CT
|
Postoperative day 30 (±7 days)
|
|
Operative time
Time Frame: From skin puncture to completion of the procedure (intraoperative period)
|
Total duration of the surgical procedure measured from puncture to completion of the operation
|
From skin puncture to completion of the procedure (intraoperative period)
|
|
Postoperative pain score
Time Frame: Postoperative day 1
|
Postoperative pain assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable.
|
Postoperative day 1
|
|
Postoperative complications
Time Frame: Postoperative day 0 to 30
|
Incidence and severity of postoperative complications classified according to the Clavien-Dindo grading system
|
Postoperative day 0 to 30
|
|
Length of postoperative hospital stay
Time Frame: Postoperative day 0 to postoperative day 14
|
Duration of hospital stay measured from completion of the procedure to hospital discharge
|
Postoperative day 0 to postoperative day 14
|
|
Quality of life score
Time Frame: Baseline and postoperative day 30
|
Health-related quality of life assessed using the Wisconsin Stone Quality of Life (WISQOL) questionnaire, which consists of 28 items scored on a 5-point Likert scale.
Total scores range from 0 to 140, with higher scores indicating better quality of life.
|
Baseline and postoperative day 30
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Calculi
- Pathological Conditions, Anatomical
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urolithiasis
- Urinary Calculi
- Nephrolithiasis
- Pathological Conditions, Signs and Symptoms
- Kidney Calculi
Other Study ID Numbers
- ES-2025-252-02 (Other Identifier: The First Affiliated Hospital of Guangzhou Medical University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stones
-
Calyxo, Inc.Not yet recruitingUrolithiasis | Kidney Stones | Renal Stones | Stones, Kidney
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
Omeros CorporationCompletedUrinary Calculi | Renal Calculi | Kidney Stones | Urinary Stones | Urinary Tract StonesUnited States
-
Mayo ClinicCompletedKidney Calculi | Nephrolithiasis | Kidney Stones | Renal StonesUnited States, Canada
-
Calyxo, Inc.RecruitingUrolithiasis | Kidney Stones | Renal Stones | Stones, KidneyUnited States
-
United States Naval Medical Center, San DiegoUnknown
-
AdventHealthNot yet recruitingKidney Calculi | Kidney Stones | Renal Stone Disease | Refractory Kidney StonesUnited States
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Robert SworWilliam Beaumont HospitalsCompletedKidney Stones | Ureteral StonesUnited States
Clinical Trials on FANS-assisted mini-percutaneous nephrolithotomy
-
The First Affiliated Hospital of Guangzhou Medical...Tongji Hospital; Shengjing Hospital; Guizhou Provincial People's Hospital; The... and other collaboratorsActive, not recruiting
-
Ain Shams UniversityRecruitingStone, Kidney | Stone Clearance | Stone, Urinary | Stone;RenalEgypt
-
The First Affiliated Hospital of Guangzhou Medical...General Hospital of Shenyang Military Region; First Affiliated Hospital of... and other collaboratorsCompletedKidney CalculiChina
-
Ain Shams UniversityRecruiting
-
Khyber Teaching HospitalCompleted
-
The First Affiliated Hospital of Guangzhou Medical...The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsNot yet recruitingKidney CalculiChina
-
Mansoura UniversityUnknownNephrolithiasis | Urolithiasis | PCNL | Stone;Renal | PNL | NEPHROLITHOTOMY | MINIPERCEgypt
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
Haseki Training and Research HospitalCompleted
-
Mansoura UniversityNot yet recruitingRenal Stones | Renal Calculi > 2 cm